Application of the Technique of Magnetic Resonance Voxel-based Morphometry in Patients with Multiple Sclerosis before and after using High-dose Immunosuppressive Therapy with Autologous Hematopoietic Stem Cell Transplantation: Preliminary Results

Correlation analysis of magnetic resonance voxel-based morphometric parameters of patients with multiple sclerosis before and after high-dose immunosuppressive therapy with transplantation of autologous hematopoietic stem cells (HDIT + AHSCT). The use of MR-morphometry methods makes it possible to quantitatively and objectively changes of the volume and size of the structures of the brain and cerebellum in patients with MS. We observed 10 patients with MS (3 men, 7 women) who underwent HDIT + AHSCT, and MRI studies were performed before and after transplantation. After postprocessing of MRI data and statistic analyses of morphometry parameters some changes were accrued: some patients showed negative dynamics in white and grey mater volumes and decrease of the absolute volume of the thalamus. Also, study showed positive dynamics in reducing the number of new MS lesions. These results can be associated with the result of treatment, with a local decrease in edema and inflammation. Study showed the need for dynamic MR control of the grey and white matter of the brain and subcortical structures with the help of MR morphometry.

[1]  M. Sormani,et al.  Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis , 2018, Multiple sclerosis.

[2]  P. Stys,et al.  Will the real multiple sclerosis please stand up? , 2012, Nature Reviews Neuroscience.

[3]  G. Nygaard,et al.  [MRI in multiple sclerosis]. , 2016, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[4]  M. Kraemer,et al.  Individual Assessment of Brain Tissue Changes in MS and the Effect of Focal Lesions on Short-Term Focal Atrophy Development in MS: A Voxel-Guided Morphometry Study , 2016, International journal of molecular sciences.

[5]  I. Krotenkova,et al.  [Atrophy of the central nervous system in multiple sclerosis: MRI-morphometry results]. , 2014, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[6]  Christian Gaser,et al.  Volume versus surface-based cortical thickness measurements: A comparative study with healthy controls and multiple sclerosis patients , 2017, PloS one.

[7]  V. Tomassini,et al.  Brain Morphometry in Multiple Sclerosis , 2018 .

[8]  B. Trapp,et al.  Multiple sclerosis: an immune or neurodegenerative disorder? , 2008, Annual review of neuroscience.

[9]  W. Brück,et al.  The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain , 2016, Brain : a journal of neurology.

[10]  E. Luders,et al.  Voxel-Based Morphometry , 2015 .

[11]  C. Ferrari,et al.  Cortical and meningeal pathology in progressive multiple sclerosis: a new therapeutic target? , 2019, Reviews in the neurosciences.

[12]  Jeffrey A. Cohen,et al.  Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function , 2017, The Lancet.

[13]  Jeffrey A. Cohen,et al.  Defining the clinical course of multiple sclerosis: the 2013 revisions. , 2014, Neurology.

[14]  B. Sharrack,et al.  Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis: a Review of Current Literature and Future Directions for Transplant Haematologists and Oncologists , 2019, Current Hematologic Malignancy Reports.

[15]  D. Ramasamy,et al.  Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine , 2018, American Journal of Neuroradiology.

[16]  P. Matthews,et al.  Thalamic neurodegeneration in multiple sclerosis , 2002, Annals of neurology.

[17]  Jeffrey A. Cohen,et al.  Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  F. Jacques Defining the clinical course of multiple sclerosis: The 2013 revisions , 2015, Neurology.

[19]  D. Pelletier,et al.  Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease , 2018, Annals of neurology.

[20]  M. Ardestani,et al.  A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future , 2018, Inflammation Research.

[21]  Vladimir A. Fokin,et al.  fMRI and Voxel-based Morphometry in Detection of Early Stages of Alzheimer's Disease , 2017, BIOIMAGING.